Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120790 · ClinicalTrials.gov registry record
Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
A clinical trial of Tracheostomy, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06120790: Recruiting study of Tracheostomy, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06120790 is a study of Tracheostomy that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 80 participants, above the 20-participant average among 3 other Tracheostomy trials with a reported enrollment target (300% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06120790, a study of Tracheostomy, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).
Primary Outcome
Swallow screen measured as pass/fail for presence or absence of aspiration
Conditions Studied
Interventions
- OTHER 3 Oz water screen
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2027-10 |
What NCT06120790 shows while recruiting
NCT06120790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 20-participant average among 3 other Tracheostomy trials with a reported enrollment target (300% higher).
The record links to 1 condition, with Tracheostomy appearing as the primary indexed condition, and to 1 intervention - of which 3 Oz water screen is the first listed.
NCT06120790 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06120790 about?
NCT06120790 is a clinical study titled "Investigation of a 3 oz Water Protocol on Patients With Tracheostomies". Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).
What is the current status of trial NCT06120790?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-05-06. Estimated completion is 2027-10.
What conditions does trial NCT06120790 study?
This clinical trial studies the following conditions: Tracheostomy.
What interventions are being tested in trial NCT06120790?
The interventions under investigation include: 3 Oz water screen (OTHER).
Who is sponsoring clinical trial NCT06120790?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06120790 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tracheostomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI